2.0
Aug 4, 2025
Former employee, more than 3 years
Blue Bell, PA
Recommend
CEO approval
Business Outlook
Pros
• Exposure to global Phase I–IV trials across various therapeutic areas • Opportunities to collaborate with experienced teams in clinical research • Use of major industry tools and systems (Veeva Vault, InForm, Siebel CTMS, etc.) • Remote work flexibility
Cons
• No merit increases or cost-of-living adjustments, even with strong performance • Promised promotions that never materialized—despite taking on higher-level responsibilities and supporting CRA-level tasks • Excessive workload due to high turnover and understaffing • Lack of transparency and communication from leadership • Sudden layoff with little notice, despite being told the team was stable and secure